Eurotimes Articles

Features

Features

Santen Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the company’s Marketing Authorisation Application (MAA) filing for the use of intravitreal sirolimus, an investigational mTOR inhibitor, for the treatment of noninfectious uveitis (NIU) of the posterior segment.

So, what did you see?” I asked the most junior resident, who thought he had a retinal detachment case in the emergency room.

The divide and conquer technique of nucleofractis is the basic technique that every phaco surgeon starts their training with. It is essentially ideal for denser nuclei and is not suitable for soft nuclei where the probe may punch a hole in the capsule before the surgeon can react.

The Oraya IRay® Radiotherapy system has received a CE Mark extension for the treatment of choroidal metastases. The new indication of use expands upon Oraya’s prior approval for the treatment of wet age-related macular degeneration (AMD).

Alamedics say the ala®heavy 1.07 is an innovative, heavy oil which can be used for the treatment of inferior retinal detachments as well as persistent macula holes. 
“What has to be highlighted is the renouncement of surfactants, density enhancers or other additives. ala®heavy 1.07 is made of one single component: pure, transparent, fluorinated silicone oil,” said a company spokesman. 

The Sail Hotel__WEB

Mies Pavelo

Popular Items